Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination of oral minoxidil, oral dutasteride, and mesotherapy is the most effective and safe for hair growth in AGA.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Apremilast shows promise for several skin conditions but needs more research.

Baricitinib shows promise for treating various skin conditions beyond alopecia areata.

Microagulhamento e intradermoterapia juntos melhoram o crescimento capilar em mulheres menopausadas.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

A new metformin-based treatment may effectively promote hair growth with fewer side effects.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Using mirabegron and solifenacin together is safe and more effective for treating overactive bladder than using either drug alone.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

GLP-1 therapies, especially semaglutide and tirzepatide, may cause hair loss, particularly in women and with rapid weight loss.

Indinavir can cause hair loss and other skin problems.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Doxazosin mesylate and saw palmetto cause genetic changes in fruit flies.

Finasteride may help reduce anxiety and depression in elderly but might cause depression in young men.

Dutasteride is more effective than finasteride for hair loss but may affect male fertility and should be used cautiously.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Gabapentin helps with scalp itch, dutasteride works for frontal fibrosing alopecia, and more research is needed for better PCA treatments.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Atorvastatin is less effective for women with Hashimoto's thyroiditis.